This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeKrey, G. K.
Right arrow Articles by Titus, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeKrey, G. K.
Right arrow Articles by Titus, R. G.

 Previous Article  |  Next Article 

Infect Immun, February 1998, p. 827-829, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Analysis of the Immune Responses of Mice to Infection with Leishmania braziliensis

Gregory K. DeKrey, Hermenio C. Lima,dagger and Richard G. Titus*

Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523-1671

Received 5 June 1997/Returned for modification 18 July 1997/Accepted 21 November 1997

    ABSTRACT
Top
Abstract
Text
References

Leishmania major and Leishmania braziliensis both cause cutaneous leishmaniasis, but the former kills BALB/c mice while the latter is killed by the mice. This killing of L. braziliensis occurred by a gamma interferon-dependent mechanism, potentially made possible by the observed lack of high interleukin-4 production.

    TEXT
Top
Abstract
Text
References

The most widely studied model for cutaneous leishmaniasis is infection of mice with Leishmania major, wherein it has been observed that certain mice (e.g., C3H) develop a parasite-specific Th1 response (high levels of gamma interferon [IFN-gamma ] and low levels of interleukin-4 [IL-4]), which often is associated with cure, while other mice (BALB/c) develop a Th2 response (low levels of IFN-gamma and high levels of IL-4), which leads to disease progression (reviewed in references 4, 8, 13, 14, and 21). In contrast, although Leishmania braziliensis induces a disease that is a serious health problem in South America, relatively little experimental work has been done to characterize the immune response to this parasite, probably because the parasite is weakly infectious for mice (6, 12). To examine why L. braziliensis is weakly infectious, we infected the same mouse strain (BALB/c) with either L. major (which kills BALB/c mice) or L. braziliensis (which BALB/c mice kill) and compared the development of cutaneous lesions and the immune responses to the two species of parasites.

The course of cutaneous lesion development following infection with L. major or L. braziliensis in BALB/c mice. BALB/cBy mice (National Cancer Institute, Frederick, Md.) were injected with either 106 L. major (R/SU/59/Neal P) (22) or 107 L. braziliensis (MAN/BR/LTB-111) (10) organisms in a hind footpad. Because L. braziliensis is weakly infectious for mice, a dose of 107 parasites was required to obtain consistent results in the assay systems used. On the other hand, because L. major is quite infectious for BALB/c mice, a lower dose of L. major (106 organisms) was used; a dose of 107 L. major organisms would have overwhelmed the mice so rapidly that there would not have been sufficient time to compare the courses of infection with the two species of parasites. Using this approach, we found that the majority of both species were killed within the first 3 days of infection. At this time the numbers of parasites remaining in the developing footpad lesions were similar for the two species (parasites were enumerated by limiting-dilution analysis; for techniques, see reference 11): 1.4 × 104 L. major organisms (95% confidence limits, 0.2 × 104 to 2.6 × 104) and 5.6 × 104 L. braziliensis organisms (confidence limits, 0.4 × 104 to 10.7 × 104). Such massive destruction of L. major within the first few days of infection has been reported before (22). Beyond day 3 postinfection, L. major replicated to achieve a 712-fold expansion by day 42 postinfection. In contrast, L. braziliensis doubled its numbers by day 7 postinfection and thereafter was gradually destroyed, so that beyond day 42 postinfection the parasite could not be detected. Cutaneous lesion development directly correlated with lesion (footpad) parasite burden. L. major induced a rapid increase in footpad size, such that by day 42 postinfection, footpad thickness had tripled and lesions had become ulcerated and necrotic (at which point the animals were sacrificed). L. braziliensis induced modest (never more than a 50% increase in footpad thickness) lesions that were nodular and never ulcerated.

Production of Th1- and Th2-associated cytokines by BALB/c mice infected with L. major or L. braziliensis. Cytokines play counteracting roles in the control (e.g., IFN-gamma ) or exacerbation (e.g., IL-4) of L. major infection. Therefore, we determined the cytokines produced by lymph node cells taken from BALB/c mice infected with either L. major or L. braziliensis. Three to five mice from each group were killed for evaluation at various times postinfection. Single-cell suspensions were prepared from the lymph nodes draining the lesion, and the cells were placed into culture as described elsewhere (20). To assess IL-4, IL-10, and IFN-gamma production, culture supernatants were harvested 72 h later (a time when peak production of the cytokines was achieved) and analyzed for the presence of the cytokines by using enzyme-linked immunosorbent assays (ELISA) described elsewhere (5, 20). For tumor necrosis factor alpha (TNF-alpha ) production, culture supernatants were harvested 6, 24, 48, and 72 h later and analyzed for TNF by ELISA (capture and detection antibodies and recombinant TNF standard were obtained from PharMingen [San Diego, Calif.]).

Because IFN-gamma plays a protective role in leishmaniasis and because BALB/c mice cure an infection with L. braziliensis, we anticipated that these mice would produce more IFN-gamma than BALB/c mice infected with L. major. BALB/c mice were infected with L. braziliensis or L. major, and at varying times after infection (day 3, 7, 21, or 42), the lymph node cells draining the lesion were assessed for IFN-gamma production. The levels of IFN-gamma produced were not different. L. braziliensis elicited 27.8 ± 13.5 ng of IFN-gamma /ml of culture supernatant, while L. major elicited 17.7 ± 7.3 (the numbers were obtained by averaging the amounts of IFN-gamma produced at the four time points ± standard deviation [SD]). Using the same approach, we also found that C3H mice infected with L. braziliensis produced an average of 47.9 ± 32.2 ng of IFN-gamma /ml of culture supernatant. Analysis of IL-10 production yielded results similar to those for IFN-gamma ; L. braziliensis elicited 2.1 ± 1.5 ng of IL-10/ml of culture supernatant, and L. major elicited 2.9 ± 1.8 ng/ml. Finally, TNF-alpha production in response to infection with either species of parasite was not detected. This inability to detect TNF-alpha production was not due to technical failure, since C3H mice produced substantial levels of TNF-alpha following infection with L. braziliensis (e.g., 257.7 pg/ml of culture supernatant at day 3 postinfection).

IL-4 plays a central role in the susceptibility of BALB/c mice to infection with L. major. Therefore, since BALB/c mice heal an infection with L. braziliensis, we predicted that less IL-4 would be produced by these mice. Significantly (by analysis by nonpaired t test; a P value of <0.05 was considered significant) less IL-4 (10- to 15-fold) was produced in response to infection with L. braziliensis than in response to infection with L. major, and by day 42 postinfection, L. braziliensis-infected mice did not produce detectable levels of IL-4 (Table 1). It should also be noted that when C3H mice are infected with L. braziliensis, the mice develop barely perceptible cutaneous lesions and never make a detectable IL-4 response (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Production of IL-4 by BALB/c mice infected with L. major or L. braziliensis

The course of cutaneous lesion development following infection with L. braziliensis in BALB/c mice treated with either anti-IFN-gamma or anti-IL-4 antibody. Because IL-4 can inhibit the protective effects of IFN-gamma in mice infected with L. major (7, 9), and because L. braziliensis-infected BALB/c mice produced significantly less IL-4 than L. major-infected BALB/c mice (Table 1), we hypothesized that the amount of IFN-gamma produced by L. braziliensis-infected mice might be sufficient to control infection. Therefore, we treated L. braziliensis-infected mice with a neutralizing anti-IFN-gamma .

First, we tested the potency of our neutralizing anti-IFN-gamma preparation (anti-IFN-gamma was purified from the ascites fluid of the anti-IFN-gamma -producing hybridoma XMG1.2 [a gift from R. Coffman, DNAX, Palo Alto, Calif.] by salt precipitation [17, 18;]) by determining whether it would prevent C3H/HeJ mice (National Cancer Institute) from healing an infection with L. major as reported by others (3). Our anti-IFN-gamma preparation converted C3H mice into animals completely susceptible to infection with L. major (see Fig. 1, inset). Since C3H mice produce considerably more IFN-gamma than BALB/c mice following infection with L. major (16), and since BALB/c mice produce equivalent amounts of the cytokine following infection with either L. braziliensis or L. major, our preparation of anti-IFN-gamma would be more than sufficient to neutralize IFN-gamma in BALB/c mice infected with L. braziliensis.

Treating L. braziliensis-infected BALB/c mice with anti-IFN-gamma (by intraperitoneal injections of 1.0 mg of XMG1.2 on the day of infection and at weekly intervals thereafter until the completion of the experiment) significantly enhanced lesion size and prevented the mice from resolving their infection (Fig. 1). In addition, anti-IFN-gamma treatment caused mice to produce more IL-4 in response to infection with L. braziliensis. For instance, at 2 weeks following infection, lymph node cells draining the lesion in treated mice produced 58.5 ± 1.6 pg of IL-4/ml (mean ± SD) when the cells were restimulated in culture with L. braziliensis. In contrast, untreated control mice produced 10.8 ± 1.6 pg of IL-4/ml, or 5.4-fold less IL-4 (in cultures not restimulated with L. braziliensis, no IL-4 was detected). Finally, by day 144 of infection, anti-IFN-gamma treatment had markedly enhanced parasite burden in the lesions (122 parasites/lesion in control mice versus 43.5 × 106 in treated mice, which is a 356,557-fold difference), which resulted in systemic infection with L. braziliensis, as evidenced by the fact that large numbers of the parasite (3.58 × 104) could be detected in the opposing (uninfected) footpad (Fig. 1). It is possible that parasites could be isolated from the opposing footpad because the L. braziliensis strain used (LTB-111) was originally isolated from a cutaneous lesion. Therefore, the parasite may prefer the lower temperature of cutaneous sites. Taken together, these data suggest that an IFN-gamma -dependent mechanism is responsible for the killing of L. braziliensis by BALB/c mice.


View larger version (27K):
[in this window]
[in a new window]
 
FIG. 1.   Course of cutaneous lesion development following infection with L. braziliensis in BALB/c mice treated with anti-IFN-gamma antibody. Each value represents the mean (± standard error of the mean) lesion size of five animals per group. The results are representative of two independent experiments. Control animals were treated with an isotype-matched antibody (1.0 mg of anti-beta -galactosidase [GL113; DNAX]/week) prepared in a fashion identical to that for the anti-IFN-gamma antibody. The asterisk indicates that from day 56 of infection and beyond, there was a significant difference (P < 0.05) in lesion size between the groups as determined by analysis of variance followed by Student-Newman-Keuls posthoc t tests. Numbers of parasites per foot in control and IFN-gamma -treated animals are given for day 144. (Inset) BALB/c and C3H mice were infected with 106 L. major organisms and left untreated or treated with anti-IFN-gamma , as indicated.

IL-4 exacerbates disease in L. major-infected BALB/c mice (15). This predicts that neutralizing IL-4 in mice infected with L. braziliensis would lessen disease severity. Lesions on anti-IL-4-treated mice (for techniques, see reference 10) infected with L. braziliensis resolved in half the time and never were greater than 20% of the size of lesions on control mice (data not shown).

These data suggest that the weak infectivity of L. braziliensis for mice may be due to the inability of the parasite to elicit strong and sustained IL-4 production in the animals. Alternatively, it is possible that L. braziliensis is unable to elicit the production of other cytokines that inhibit the development of a Th1 response. IL-10 inhibits Th1 development; however, BALB/c mice produced equivalent amounts of IL-10 following infection with either L. braziliensis or L. major (see above). Transforming growth factor beta  (TGF-beta ) also inhibits Th1 responses. TGF-beta correlates with susceptibility to infection with both L. braziliensis (2; reviewed in reference 13) and L. major (19). However, we have been unable to detect TGF-beta (protein or mRNA, in vitro or in vivo) following infection with L. braziliensis. Since different isolates of L. braziliensis vary in their ability to induce TGF-beta production (1), it is possible that LTB-111 is a poor inducer of TGF-beta .

In conclusion, the data presented here extend the Th1 (protective)/Th2 (exacerbative) paradigm in leishmaniasis established by injection of different mouse strains with L. major. However, the approach taken here is unique. The Th1/Th2 paradigm with L. major was formulated by injecting different mouse strains with the parasite or by injecting the same mouse strain with the parasite followed by intervention with neutralizing anti-cytokines (anti-IL-4 or anti-IFN-gamma ) (reviewed in references 4, 8, 13, 14, and 21). Here, the same mouse strain (BALB/c) was injected with two leishmanial species that cause cutaneous disease; parasites that elicited a strong Th2 (IL-4) response survived (L. major), while those that did not (L. braziliensis) were killed.

    ACKNOWLEDGMENTS

This work was supported by NIH grant AI-29955. H.C.L. received partial support from a World Health Organization TDR-WHO scholarship (M8/181/4/L.238).

The technical assistance of Monica Estay and Julie Bleyenberg is gratefully acknowledged.

    FOOTNOTES

* Corresponding author. Mailing address: Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1671. Phone: (970) 491-4964. Fax: (970) 491-0603. E-mail: rtitus{at}vines.colostate.edu.

dagger Present address: Departamento de Parasitologia, Microbiologia e Imunologia, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo---Campus de Ribeirao Preto, Ribeirao Preto SP 14.049- 900, Brazil.

Editor:  S. H. E. Kaufmann

    REFERENCES
Top
Abstract
Text
References

1. Barral, A., M. Barral-Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor beta  as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90:3442-3446[Abstract/Free Full Text].
2. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. W. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257:545-548[Abstract/Free Full Text].
3. Belosevic, M., D. S. Finbloom, P. van der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266-274[Abstract].
4. Bogdan, C., A. Gessner, and M. Rollinghoff. 1993. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189:356-396[Medline].
5. Chakkalath, H. R., and R. G. Titus. 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153:4378-4387[Abstract].
6. Childs, G. E., L. K. Lighther, L. A. McKinney, M. Groves, E. Price, and L. Hendricks. 1984. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana and L. aethiopica. Ann. Trop. Med. Parasitol. 78:25-34[Medline].
7. Lehn, M., W. Y. Weiser, S. Engelhorn, S. Gillis, and H. G. Remold. 1989. IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma . J. Immunol. 143:3020-3024[Abstract].
8. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:161-259[Medline].
9. Liew, F. Y., S. Millott, Y. Li, R. Lelchuk, W. L. Chan, and H. Ziltener. 1989. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL) 3 and IL-4 produced by disease-promoting T cells in leishmaniasis. Eur. J. Immunol. 19:1227-1232[Medline].
10. Lima, H. C., and R. G. Titus. 1996. Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect. Immun. 64:5442-5445[Abstract].
11. Lima, H. C., J. A. Bleyenberg, and R. G. Titus. 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol. Today 13:80-82. [Medline]
12. Neal, R. A., and C. Hale. 1983. A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases. Parasitology 87:7-13.
13. Reed, S. G., and P. Scott. 1993. T-cell and cytokine responses in leishmaniasis. Curr. Opin. Immunol. 5:524-531[Medline].
14. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177[Medline].
15. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma -independent mechanism. J. Exp. Med. 171:115-127[Abstract/Free Full Text].
16. Scharton-Kersten, T., and P. Scott. 1995. The role of the innate immune response in Th1 cell development following Leishmania major infection. J. Leukocyte Biol. 57:515-522[Abstract].
17. Shankar, A., and R. G. Titus. 1993. Leishmania major-specific, CD4+, MHC class-II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J. Exp. Med. 178:101-111[Abstract/Free Full Text].
18. Shankar, A. H., and R. G. Titus. 1997. The influence of antigen presenting cell type and IFN-gamma on priming and cytokine secretion of Leishmania major-specific T cells. J. Infect. Dis. 175:151-157[Medline].
19. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793[Abstract/Free Full Text].
20. Theodos, C. M., A. Shankar, A. L. Glasebrook, W. D. Roeder, and R. G. Titus. 1994. The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol. 16:571-577[Medline].
21. Titus, R. G., C. M. Theodos, A. Shankar, and L. R. Hall. 1994. Interactions between Leishmania major and macrophages. Immunol. Ser. 60:437-459[Medline].
22. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555[Medline].


Infect Immun, February 1998, p. 827-829, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Vargas-Inchaustegui, D. A., Tai, W., Xin, L., Hogg, A. E., Corry, D. B., Soong, L. (2009). Distinct Roles for MyD88 and Toll-Like Receptor 2 during Leishmania braziliensis Infection in Mice. Infect. Immun. 77: 2948-2956 [Abstract] [Full Text]  
  • Vargas-Inchaustegui, D. A., Xin, L., Soong, L. (2008). Leishmania braziliensis Infection Induces Dendritic Cell Activation, ISG15 Transcription, and the Generation of Protective Immune Responses. J. Immunol. 180: 7537-7545 [Abstract] [Full Text]  
  • Rocha, F. J. S., Schleicher, U., Mattner, J., Alber, G., Bogdan, C. (2007). Cytokines, Signaling Pathways, and Effector Molecules Required for the Control of Leishmania (Viannia) braziliensis in Mice. Infect. Immun. 75: 3823-3832 [Abstract] [Full Text]  
  • TONUI, W. K., TITUS, R. G. (2007). CROSS-PROTECTION AGAINST LEISHMANIA DONOVANI BUT NOT L. BRAZILIENSIS CAUSED BY VACCINATION WITH L. MAJOR SOLUBLE PROMASTIGOTE EXOGENOUS ANTIGENS IN BALB/C MICE. Am J Trop Med Hyg 76: 579-584 [Abstract] [Full Text]  
  • de Moura, T. R., Novais, F. O., Oliveira, F., Clarencio, J., Noronha, A., Barral, A., Brodskyn, C., de Oliveira, C. I. (2005). Toward a Novel Experimental Model of Infection To Study American Cutaneous Leishmaniasis Caused by Leishmania braziliensis. Infect. Immun. 73: 5827-5834 [Abstract] [Full Text]  
  • Theodos, C. M., Morris, R. V., Bishop, J. V., Jones, J. D., McMaster, W. R., Titus, R. G. (2004). Characterization of an I-E-Restricted, gp63-Specific, CD4-T-Cell Clone from Leishmania major-Resistant C3H Mice That Secretes Type 2 Cytokines and Exacerbates Infection with L. major. Infect. Immun. 72: 4486-4493 [Abstract] [Full Text]  
  • Jones, D. E., Ackermann, M. R., Wille, U., Hunter, C. A., Scott, P. (2002). Early Enhanced Th1 Response after Leishmania amazonensis Infection of C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to Resolution of Infection. Infect. Immun. 70: 2151-2158 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeKrey, G. K.
Right arrow Articles by Titus, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeKrey, G. K.
Right arrow Articles by Titus, R. G.